DNAprint Genomics (DNAG)

[worktoplay]

66fan...As you are aware, I have a very personal interest in the issue of cancer treatment. You hit it pretty much on the head.

Taxol is first line treatment. When a woman walks into a clinic and is diagnosed with Ovarian cancer, she will be prescribed Taxol. It's great to be able to identify the responders/nonresponders, if for nothing else, the peace of mind that the responders would get when the Doctor could tell her that new science can assure her a 95% chance of responding to the treatement. But in the end, she would have responded regardless of whether she knew or not. In other words, the survival rate of the responders will not change because of this test.

As for the non-responders, it's great that they can avoid the treatments (they're no picnic), but they still have the disease. On top of that, they are told that they in all likelihood will NOT respond to the normally prescribed treatment. These are the patients that need to be addressed, and these are the patients that will allow the OVERALL survival rates for the disease to be improved.

Just knowing who will or won't respond won't change the survival statistics for the disease. The key is to then be able to help the identified non-responders. I pray to God they are successful.

Later,
W2P